메뉴 건너뛰기




Volumn 214, Issue 2, 2010, Pages 240-247

Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat

Author keywords

Asenapine; D Amphetamine; Olanzapine; PCP; Reversal learning; Risperidone; Schizophrenia

Indexed keywords

ASENAPINE; DEXAMPHETAMINE; OLANZAPINE; PHENCYCLIDINE; PSYCHEDELIC AGENT; RISPERIDONE;

EID: 77955273672     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.05.043     Document Type: Article
Times cited : (43)

References (58)
  • 1
    • 33847125372 scopus 로고    scopus 로고
    • Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat
    • Abdul-Monim Z., Neill J.C., Reynolds G.P. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol 2007, 21:198-205.
    • (2007) J Psychopharmacol , vol.21 , pp. 198-205
    • Abdul-Monim, Z.1    Neill, J.C.2    Reynolds, G.P.3
  • 2
    • 12244296144 scopus 로고    scopus 로고
    • The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat
    • Abdul-Monim Z., Reynolds G.P., Neill J.C. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol 2003, 17:57-65.
    • (2003) J Psychopharmacol , vol.17 , pp. 57-65
    • Abdul-Monim, Z.1    Reynolds, G.P.2    Neill, J.C.3
  • 3
    • 33645056175 scopus 로고    scopus 로고
    • The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm
    • Abdul-Monim Z., Reynolds G.P., Neill J.C. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behav Brain Res 2006, 169:263-273.
    • (2006) Behav Brain Res , vol.169 , pp. 263-273
    • Abdul-Monim, Z.1    Reynolds, G.P.2    Neill, J.C.3
  • 4
    • 0035970691 scopus 로고    scopus 로고
    • Neurocognitive and social functioning in schizophrenia and other diagnoses
    • Addington J., Addington D., Gasbarre L. Neurocognitive and social functioning in schizophrenia and other diagnoses. Schizophr Res 2001, 48:367-368.
    • (2001) Schizophr Res , vol.48 , pp. 367-368
    • Addington, J.1    Addington, D.2    Gasbarre, L.3
  • 5
    • 0034055690 scopus 로고    scopus 로고
    • Serotonin model of schizophrenia: emerging role of glutamate mechanisms
    • Aghajanian G.K., Marek G.J. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 2000, 31:302-312.
    • (2000) Brain Res Brain Res Rev , vol.31 , pp. 302-312
    • Aghajanian, G.K.1    Marek, G.J.2
  • 6
    • 34347204172 scopus 로고    scopus 로고
    • Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex
    • Amargos-Bosch M., Adell A., Artigas F. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex. J Neurochem 2007, 102:550-561.
    • (2007) J Neurochem , vol.102 , pp. 550-561
    • Amargos-Bosch, M.1    Adell, A.2    Artigas, F.3
  • 7
    • 0034054949 scopus 로고    scopus 로고
    • Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists
    • Anand A., Charney D.S., Oren D.A., Berman R.M., Hu X.S., Cappiello A., et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists. Arch Gen Psychiatry 2000, 57:270-276.
    • (2000) Arch Gen Psychiatry , vol.57 , pp. 270-276
    • Anand, A.1    Charney, D.S.2    Oren, D.A.3    Berman, R.M.4    Hu, X.S.5    Cappiello, A.6
  • 8
    • 0036268294 scopus 로고    scopus 로고
    • Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
    • Bilder R.M., Goldman R.S., Volavka J., Czobor P., Hoptman M., Sheitman B., et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002, 159:1018-1028.
    • (2002) Am J Psychiatry , vol.159 , pp. 1018-1028
    • Bilder, R.M.1    Goldman, R.S.2    Volavka, J.3    Czobor, P.4    Hoptman, M.5    Sheitman, B.6
  • 9
    • 0035280269 scopus 로고    scopus 로고
    • Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study
    • Cuesta M.J., Peralta V., Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 2001, 48:17-28.
    • (2001) Schizophr Res , vol.48 , pp. 17-28
    • Cuesta, M.J.1    Peralta, V.2    Zarzuela, A.3
  • 10
    • 33947121649 scopus 로고    scopus 로고
    • F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia
    • Depoortere R., Bardin L., Auclair A.L., Kleven M.S., Prinssen E., Colpaert F., et al. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia. Br J Pharmacol 2007, 151:253-265.
    • (2007) Br J Pharmacol , vol.151 , pp. 253-265
    • Depoortere, R.1    Bardin, L.2    Auclair, A.L.3    Kleven, M.S.4    Prinssen, E.5    Colpaert, F.6
  • 11
    • 34347369304 scopus 로고    scopus 로고
    • Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics
    • Didriksen M., Skarsfeldt T., Arnt J. Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics. Psychopharmacology (Berlin) 2007, 193:225-233.
    • (2007) Psychopharmacology (Berlin) , vol.193 , pp. 225-233
    • Didriksen, M.1    Skarsfeldt, T.2    Arnt, J.3
  • 12
    • 0038402678 scopus 로고    scopus 로고
    • Insight and neurocognition in schizophrenia
    • Drake R.J., Lewis S.W. Insight and neurocognition in schizophrenia. Schizophr Res 2003, 62:165-173.
    • (2003) Schizophr Res , vol.62 , pp. 165-173
    • Drake, R.J.1    Lewis, S.W.2
  • 17
    • 34548348729 scopus 로고    scopus 로고
    • Molecular targets for treating cognitive dysfunction in schizophrenia
    • Gray J.A., Roth B.L. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr Bull 2007, 33:1100-1119.
    • (2007) Schizophr Bull , vol.33 , pp. 1100-1119
    • Gray, J.A.1    Roth, B.L.2
  • 18
    • 34548621479 scopus 로고    scopus 로고
    • Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat
    • Grayson B., Idris N.F., Neill J.C. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behav Brain Res 2007, 184:31-38.
    • (2007) Behav Brain Res , vol.184 , pp. 31-38
    • Grayson, B.1    Idris, N.F.2    Neill, J.C.3
  • 19
    • 0029918481 scopus 로고    scopus 로고
    • What are the functional consequences of neurocognitive deficits in schizophrenia?
    • Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996, 153:321-330.
    • (1996) Am J Psychiatry , vol.153 , pp. 321-330
    • Green, M.F.1
  • 20
    • 33747329318 scopus 로고    scopus 로고
    • Pharmacological approaches to the management of cognitive dysfunction in schizophrenia
    • Harvey P.D., McClure M.M. Pharmacological approaches to the management of cognitive dysfunction in schizophrenia. Drugs 2006, 66:1465-1473.
    • (2006) Drugs , vol.66 , pp. 1465-1473
    • Harvey, P.D.1    McClure, M.M.2
  • 22
    • 33751162382 scopus 로고    scopus 로고
    • SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models
    • Hirst W.D., Stean T.O., Rogers D.C., Sunter D., Pugh P., Moss S.F., et al. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 2006, 553:109-119.
    • (2006) Eur J Pharmacol , vol.553 , pp. 109-119
    • Hirst, W.D.1    Stean, T.O.2    Rogers, D.C.3    Sunter, D.4    Pugh, P.5    Moss, S.F.6
  • 23
    • 53949102049 scopus 로고    scopus 로고
    • Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus
    • Huang M., Li Z., Dai J., Shahid M., Wong E.H., Meltzer H.Y. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus. Neuropsychopharmacology 2008, 33:2934-2945.
    • (2008) Neuropsychopharmacology , vol.33 , pp. 2934-2945
    • Huang, M.1    Li, Z.2    Dai, J.3    Shahid, M.4    Wong, E.H.5    Meltzer, H.Y.6
  • 24
    • 72649104250 scopus 로고    scopus 로고
    • Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms
    • Idris N., Neill J., Grayson B., Bang-Andersen B., Witten L.M., Brennum L.T., et al. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacology (Berlin) 2010, 208:23-36.
    • (2010) Psychopharmacology (Berlin) , vol.208 , pp. 23-36
    • Idris, N.1    Neill, J.2    Grayson, B.3    Bang-Andersen, B.4    Witten, L.M.5    Brennum, L.T.6
  • 25
    • 26444535836 scopus 로고    scopus 로고
    • Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat
    • Idris N.F., Repeto P., Neill J.C., Large C.H. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat. Psychopharmacology (Berlin) 2005, 179:336-348.
    • (2005) Psychopharmacology (Berlin) , vol.179 , pp. 336-348
    • Idris, N.F.1    Repeto, P.2    Neill, J.C.3    Large, C.H.4
  • 26
    • 0030862672 scopus 로고    scopus 로고
    • Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
    • Jentsch J.D., Redmond D.E., Elsworth J.D., Taylor J.R., Youngren K.D., Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 1997, 277:953-955.
    • (1997) Science , vol.277 , pp. 953-955
    • Jentsch, J.D.1    Redmond, D.E.2    Elsworth, J.D.3    Taylor, J.R.4    Youngren, K.D.5    Roth, R.H.6
  • 27
    • 0032903301 scopus 로고    scopus 로고
    • The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
    • Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20:201-225.
    • (1999) Neuropsychopharmacology , vol.20 , pp. 201-225
    • Jentsch, J.D.1    Roth, R.H.2
  • 28
    • 0035205333 scopus 로고    scopus 로고
    • Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats
    • Jentsch J.D., Taylor J.R. Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology 2001, 24:66-74.
    • (2001) Neuropsychopharmacology , vol.24 , pp. 66-74
    • Jentsch, J.D.1    Taylor, J.R.2
  • 29
    • 0030851961 scopus 로고    scopus 로고
    • Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat
    • Jentsch J.D., Tran A., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 1997, 17:92-99.
    • (1997) Neuropsychopharmacology , vol.17 , pp. 92-99
    • Jentsch, J.D.1    Tran, A.2    Le, D.3    Youngren, K.D.4    Roth, R.H.5
  • 30
    • 0025907854 scopus 로고
    • Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates
    • Jones G.H., Marsden C.A., Robbins T.W. Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates. Behav Brain Res 1991, 43:35-50.
    • (1991) Behav Brain Res , vol.43 , pp. 35-50
    • Jones, G.H.1    Marsden, C.A.2    Robbins, T.W.3
  • 31
    • 0037405871 scopus 로고    scopus 로고
    • Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy
    • Kapur S., VanderSpek S.C., Brownlee B.A., Nobrega J.N. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 2003, 305:625-631.
    • (2003) J Pharmacol Exp Ther , vol.305 , pp. 625-631
    • Kapur, S.1    VanderSpek, S.C.2    Brownlee, B.A.3    Nobrega, J.N.4
  • 32
    • 34247643916 scopus 로고    scopus 로고
    • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
    • Keefe R.S., Bilder R.M., Davis S.M., Harvey P.D., Palmer B.W., Gold J.M., et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 2007, 64:633-647.
    • (2007) Arch Gen Psychiatry , vol.64 , pp. 633-647
    • Keefe, R.S.1    Bilder, R.M.2    Davis, S.M.3    Harvey, P.D.4    Palmer, B.W.5    Gold, J.M.6
  • 33
    • 0142095005 scopus 로고    scopus 로고
    • NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
    • Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berlin) 2003, 169:215-233.
    • (2003) Psychopharmacology (Berlin) , vol.169 , pp. 215-233
    • Krystal, J.H.1    D'Souza, D.C.2    Mathalon, D.3    Perry, E.4    Belger, A.5    Hoffman, R.6
  • 34
    • 2342614121 scopus 로고    scopus 로고
    • Should cognitive deficit be a diagnostic criterion for schizophrenia?
    • Lewis R. Should cognitive deficit be a diagnostic criterion for schizophrenia?. J Psychiatry Neurosci 2004, 29:102-113.
    • (2004) J Psychiatry Neurosci , vol.29 , pp. 102-113
    • Lewis, R.1
  • 37
    • 0032517108 scopus 로고    scopus 로고
    • Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats
    • Martin P., Carlsson M.L., Hjorth S. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport 1998, 9:2985-2988.
    • (1998) Neuroreport , vol.9 , pp. 2985-2988
    • Martin, P.1    Carlsson, M.L.2    Hjorth, S.3
  • 39
    • 40849097398 scopus 로고    scopus 로고
    • A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats
    • McLean S.L., Beck J.P., Woolley M.L., Neill J.C. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats. Behav Brain Res 2008, 189:152-158.
    • (2008) Behav Brain Res , vol.189 , pp. 152-158
    • McLean, S.L.1    Beck, J.P.2    Woolley, M.L.3    Neill, J.C.4
  • 40
    • 70349575345 scopus 로고    scopus 로고
    • Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat
    • McLean S.L., Idris N.F., Woolley M.L., Thomas D., Neill J.C. Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. Psychopharmacology 2009, 206(3):403-414.
    • (2009) Psychopharmacology , vol.206 , Issue.3 , pp. 403-414
    • McLean, S.L.1    Idris, N.F.2    Woolley, M.L.3    Thomas, D.4    Neill, J.C.5
  • 41
    • 65049085795 scopus 로고    scopus 로고
    • D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia
    • McLean S.L., Idris N.F., Woolley M.L., Neill J.C. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia. Eur Neuropsychopharmacol 2009, 19:440-450.
    • (2009) Eur Neuropsychopharmacol , vol.19 , pp. 440-450
    • McLean, S.L.1    Idris, N.F.2    Woolley, M.L.3    Neill, J.C.4
  • 42
    • 65049088927 scopus 로고    scopus 로고
    • 6 antagonists improve a subchronic phencyclidine-induced reversal learning deficit in rats
    • 6 antagonists improve a subchronic phencyclidine-induced reversal learning deficit in rats. Schizophr Res 2008, 102:60.
    • (2008) Schizophr Res , vol.102 , pp. 60
    • Neill, J.C.1    Idris, N.F.2    Arnt, J.3
  • 43
    • 34548255299 scopus 로고    scopus 로고
    • Executive function in schizophrenia: what impact do antipsychotics have?
    • O'Grada C., Dinan T. Executive function in schizophrenia: what impact do antipsychotics have?. Hum Psychopharmacol 2007, 22:397-406.
    • (2007) Hum Psychopharmacol , vol.22 , pp. 397-406
    • O'Grada, C.1    Dinan, T.2
  • 44
    • 0032694066 scopus 로고    scopus 로고
    • NMDA receptor hypofunction model of schizophrenia
    • Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999, 33:523-533.
    • (1999) J Psychiatr Res , vol.33 , pp. 523-533
    • Olney, J.W.1    Newcomer, J.W.2    Farber, N.B.3
  • 45
    • 35948982974 scopus 로고    scopus 로고
    • Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial
    • Potkin S.G., Cohen M., Panagides J. Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial. J Clin Psychiatry 2007, 68:1492-1500.
    • (2007) J Clin Psychiatry , vol.68 , pp. 1492-1500
    • Potkin, S.G.1    Cohen, M.2    Panagides, J.3
  • 48
    • 58649100010 scopus 로고    scopus 로고
    • Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
    • Shahid M., Walker G., Zorn S., Wong E. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol 2009, 23:65-73.
    • (2009) J Psychopharmacol , vol.23 , pp. 65-73
    • Shahid, M.1    Walker, G.2    Zorn, S.3    Wong, E.4
  • 49
    • 0032588207 scopus 로고    scopus 로고
    • The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset
    • Smith A.G., Neill J.C., Costall B. The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset. Pharmacol Biochem Behav 1999, 63:201-211.
    • (1999) Pharmacol Biochem Behav , vol.63 , pp. 201-211
    • Smith, A.G.1    Neill, J.C.2    Costall, B.3
  • 50
    • 38049057135 scopus 로고    scopus 로고
    • Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats-a preliminary investigation
    • Snigdha S., Neill J.C. Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats-a preliminary investigation. Behav Brain Res 2008, 187:489-494.
    • (2008) Behav Brain Res , vol.187 , pp. 489-494
    • Snigdha, S.1    Neill, J.C.2
  • 51
    • 33846001008 scopus 로고    scopus 로고
    • Influence of gender on working and spatial memory in the novel object recognition task in the rat
    • Sutcliffe J.S., Marshall K.M., Neill J.C. Influence of gender on working and spatial memory in the novel object recognition task in the rat. Behav Brain Res 2007, 177:117-125.
    • (2007) Behav Brain Res , vol.177 , pp. 117-125
    • Sutcliffe, J.S.1    Marshall, K.M.2    Neill, J.C.3
  • 52
    • 54249140917 scopus 로고    scopus 로고
    • Oestradiol attenuates the cognitive deficit induced by acute phencyclidine treatment in mature female hooded-Lister rats
    • Sutcliffe J.S., Rhaman F., Marshall K.M., Neill J.C. Oestradiol attenuates the cognitive deficit induced by acute phencyclidine treatment in mature female hooded-Lister rats. J Psychopharmacol 2008, 22:918-922.
    • (2008) J Psychopharmacol , vol.22 , pp. 918-922
    • Sutcliffe, J.S.1    Rhaman, F.2    Marshall, K.M.3    Neill, J.C.4
  • 53
    • 59449098923 scopus 로고    scopus 로고
    • Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions
    • Tait D.S., Marston H.M., Shahid M., Brown V.J. Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions. Psychopharmacology (Berlin) 2009, 202:295-306.
    • (2009) Psychopharmacology (Berlin) , vol.202 , pp. 295-306
    • Tait, D.S.1    Marston, H.M.2    Shahid, M.3    Brown, V.J.4
  • 54
    • 66049164000 scopus 로고    scopus 로고
    • Asenapine induces differential regional effects on serotonin receptor subtypes
    • [Epub ahead of print]
    • Tarazi F.I., Moran-Gates T., Wong E.H., Henry B., Shahid M. Asenapine induces differential regional effects on serotonin receptor subtypes. J Psychopharmacol 2008, [Epub ahead of print].
    • (2008) J Psychopharmacol
    • Tarazi, F.I.1    Moran-Gates, T.2    Wong, E.H.3    Henry, B.4    Shahid, M.5
  • 55
    • 43049098484 scopus 로고    scopus 로고
    • Differential regional and dose-related effects of asenapine on dopamine receptor subtypes
    • Tarazi F.I., Moran-Gates T., Wong E.H., Henry B., Shahid M. Differential regional and dose-related effects of asenapine on dopamine receptor subtypes. Psychopharmacology (Berlin) 2008, 198:103-111.
    • (2008) Psychopharmacology (Berlin) , vol.198 , pp. 103-111
    • Tarazi, F.I.1    Moran-Gates, T.2    Wong, E.H.3    Henry, B.4    Shahid, M.5
  • 56
    • 26444518328 scopus 로고    scopus 로고
    • SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit
    • Terranova J.P., Chabot C., Barnouin M.C., Perrault G., Depoortere R., Griebel G., et al. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology (Berlin) 2005, 181:134-144.
    • (2005) Psychopharmacology (Berlin) , vol.181 , pp. 134-144
    • Terranova, J.P.1    Chabot, C.2    Barnouin, M.C.3    Perrault, G.4    Depoortere, R.5    Griebel, G.6
  • 57
    • 0041737724 scopus 로고    scopus 로고
    • Comparison of the effects of antipsychotics on a delayed radial maze task in the rat
    • Wolff M.C., Leander J.D. Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology (Berlin) 2003, 168:410-416.
    • (2003) Psychopharmacology (Berlin) , vol.168 , pp. 410-416
    • Wolff, M.C.1    Leander, J.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.